Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
- DOI
- 10.2340/actadv.v106.adv-2025-0160
- Published
- 2026 May 21
- Container
- Acta dermato-venereologica
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2340/actadv.v106.adv-2025-0160,
title = {Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.},
author = {Thaçi D and Puig L and Motegi SI and Papp K and Stein Gold L and Kircik L and Sofen H and Fernández-Peñas P and Herranz P and Vestergaard C and Huang YH and Dossenbach M and Elmaraghy H and Gallo G and Rueda MJ and Casillas M and Yang C and Agell H and Falqués M and Nosbaum A},
year = {2026},
journal = {Acta dermato-venereologica},
doi = {10.2340/actadv.v106.adv-2025-0160},
url = {https://doi.org/10.2340/actadv.v106.adv-2025-0160}
}RIS
TY - JOUR TI - Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials. AU - Thaçi D AU - Puig L AU - Motegi SI AU - Papp K AU - Stein Gold L AU - Kircik L AU - Sofen H AU - Fernández-Peñas P AU - Herranz P AU - Vestergaard C AU - Huang YH AU - Dossenbach M AU - Elmaraghy H AU - Gallo G AU - Rueda MJ AU - Casillas M AU - Yang C AU - Agell H AU - Falqués M AU - Nosbaum A PY - 2026 JO - Acta dermato-venereologica DO - 10.2340/actadv.v106.adv-2025-0160 UR - https://doi.org/10.2340/actadv.v106.adv-2025-0160 ER -
APA
D, T., L, P., SI, M., K, P., L, S. G., L, K., H, S., P, F., P, H., C, V., YH, H., M, D., H, E., G, G., MJ, R., M, C., C, Y., H, A., M, F., & A, N. (2026). Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.. Acta dermato-venereologica. https://doi.org/10.2340/actadv.v106.adv-2025-0160
Source records
- pubmed · retrieved 2026-09-26T06:03:32.531Z